Literature DB >> 2673537

Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells.

D A Cheresh1, S A Berliner, V Vicente, Z M Ruggeri.   

Abstract

Endothelial cells and activated platelets express integrin-type receptors responsible for adhesion to fibrinogen. We have located distinct integrin-directed endothelial cell and platelet attachment sites on immobilized fibrinogen using a combination of synthetic peptides, fibrinogen fragments, and specific anti-peptide monoclonal antibodies. Endothelial cells exclusively recognize an Arg-Gly-Asp-containing site near the C-terminus of the alpha chain (alpha residues 572-574) but fail to recognize the Arg-Gly-Asp sequence in the N-terminal region of the same chain (alpha residues 95-97). In contrast, platelets do not require either Arg-Gly-Asp sequence for binding to intact fibrinogen and are capable of recognizing, in addition to the alpha 572-574 sequence, a site at the C-terminus of the gamma chain (gamma residues 400-411). These data suggest a molecular mechanism whereby platelets and endothelial cells interact with distinct sites on the fibrinogen molecule during hemostasis and wound healing.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673537     DOI: 10.1016/0092-8674(89)90946-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  66 in total

1.  The crystal structure of modified bovine fibrinogen.

Authors:  J H Brown; N Volkmann; G Jun; A H Henschen-Edman; C Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell-platelet interaction?

Authors:  H Chopra; J Timar; X Rong; I M Grossi; J S Hatfield; S E Fligiel; C A Finch; J D Taylor; K V Honn
Journal:  Clin Exp Metastasis       Date:  1992-03       Impact factor: 5.150

3.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 4.  Bioactive polymer scaffold for fabrication of vascularized engineering tissue.

Authors:  Irza Sukmana
Journal:  J Artif Organs       Date:  2012-04-21       Impact factor: 1.731

5.  Lack of effect of thrombin on fibrin(ogen)-endothelial cell interaction.

Authors:  E Réganon; V Vila; V Martínez-Sales; J Aznar
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

6.  Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.

Authors:  T E O'Toole; J C Loftus; X P Du; A A Glass; Z M Ruggeri; S J Shattil; E F Plow; M H Ginsberg
Journal:  Cell Regul       Date:  1990-11

7.  mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.

Authors:  Andrew S Weyrich; Melvin M Denis; Hansjorg Schwertz; Neal D Tolley; Jason Foulks; Eliott Spencer; Larry W Kraiss; Kurt H Albertine; Thomas M McIntyre; Guy A Zimmerman
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

8.  The role of extracellular matrix in peripheral nerve regeneration: a wound chamber study.

Authors:  H M Liu
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.

Authors:  F Lanza; A Stierlé; D Fournier; M Morales; G André; A T Nurden; J P Cazenave
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.

Authors:  A S Bayer; P M Sullam; M Ramos; C Li; A L Cheung; M R Yeaman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.